2719. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Adults 18–55 Years of Age

BACKGROUND: The MenACYW-TT conjugate vaccine is a quadrivalent meningococcal vaccine that contains tetanus toxoid as carrier protein. The vaccine is intended for global use in all age groups (i.e., individuals 6 weeks of age and older). This Phase III study evaluated the immune lot consistency, and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Open Forum Infect Dis
Main Authors: Peterson, James, Hedrick, James, Pan, Judy, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Abstracts
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810173/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.2396
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki